| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9412 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2- | 0.5534 |
| P-glycoprotein Substrate | Substrate | 0.5859 |
| P-glycoprotein Inhibitor | Inhibitor | 0.6067 |
| Inhibitor | 0.5066 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.5153 |
| Distribution |
| Subcellular localization | Lysosome | 0.6334 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7727 |
| CYP450 2D6 Substrate | Non-substrate | 0.7101 |
| CYP450 3A4 Substrate | Substrate | 0.6120 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8077 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8990 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.6821 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7878 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7027 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7828 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.5238 |
| Inhibitor | 0.5413 |
| AMES Toxicity | Non AMES toxic | 0.5834 |
| Carcinogens | Non-carcinogens | 0.9194 |
| Fish Toxicity | High FHMT | 0.6310 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9044 |
| Honey Bee Toxicity | Low HBT | 0.7394 |
| Biodegradation | Not ready biodegradable | 0.9908 |
| Acute Oral Toxicity | III | 0.7352 |
| Carcinogenicity (Three-class) | Non-required | 0.5181 |